All Vyluma Articles
-
201ClinicalThe Ins and Outs of Vyluma’s CHAMP Study
sponsored content June 1, 2023 By Kristen Dalli, Managing Editor, Review of Myopia Management At this year’s Global Specialty Lens Symposium, Mark...
-
346ClinicalVyluma’s Navneet Puri and Raul Trillo Discuss CHAMP Study Results
sponsored content November 1, 2022 Review of Myopia Management’s Chief Medical Editor Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE, interviewed Vyluma executives...
-
1.6KClinicalVyluma CHAMP Pivotal Phase 3 Clinical Trial Q&A
sponsored content October 27, 2022 Vyluma aims to preserve the vision of a global population by providing meaningful and effective pharmaceutical ophthalmic...
-
916Latest Myopia NewsVyluma Checks Off Last Patient Visit for NVK002 Clinical Trial
September 1, 2022 BRIDGEWATER, N.J. — Vyluma has checked off an important step in its Phase III CHAMP (Childhood Atropine for Myopia...
-
1.1KLatest Myopia NewsVyluma and Laboratories Théa Enter Licensing Agreement for NVK002
June 14, 2022 BRIDGEWATER, N.J. — Vyluma and Laboratories Théa have entered into an exclusive licensing agreement for the registration and commercialization...
-
781ClinicalThe 2021 Year in Review for Myopia Management
sponsored content January 3, 2022 By Neal Wolff, Vice President and Head of Marketing, Vylmua This year, awareness and understanding of myopia...
-
1.6KLatest Myopia NewsVyluma and MyMyopia.com Announce Plans to Support World Sight Day
October 8, 2021 BRIDGEWATER, NJ — To show support for the International Agency for the Prevention of Blindness‘ (IAPB) 2021 World Sight...
-
2.7KClinicalVyluma: Leading with Innovation
sponsored content October 1, 2021 By Dwight Akerman, OD, MBA, FAAO, FBCLA Vyluma is dedicated to using its deep expertise to develop...
-
1.8KLatest Myopia News
Nevakar Launches New Ophthalmic Company Vyluma
May 25, 2021 BRIDGEWATER, NJ — Nevakar has launched Vyluma, a new company that will create treatments for ophthalmic diseases such as...